Post #23 The following is brought to you by Intellivest Securities Research, Inc. The following is not intended as advertising by a broker-dealer and is not a research report. Click at the 7/23/09 Blog to find a description of this week's profiled company, AXP American Express Company. AXP was today's biggest loser, dropping 1.13 to close at $28.38 down 3.83% with volume of 23,110,257 on NYSE.
The Dow closed Monday at 9108.51 up 15.27 or 0.17% from Friday's close of 9093.24. Of the 30 Dow Companies: 17 gained and 18 declined with the biggest gainer being CAT Caterpillar $42.86 +0.86 2.05% 14,309,600 NYSE and, as mentioned above, the biggest loser being AXP Amex $28.38 -1.13 3.83% 23,110,257 NYSE.
The current divisor for the Dow found at today's page C4 of The Wall St. Jrnl is .132319125 unchanged.
Monday's Dow closing numerator was 1205.23 up 2.02 from Friday's Dow closing numerator of 1203.21. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor.
Now, if you divide the Dow numerator increase of 2.02 by the divisor you get 15.27, the increase in Monday's Dow numerator.
The average closing price (the closing numerator divided by 30) of Monday's Dow Jones was 40.17 up 0.06 from Friday's average closing price of 40.11. The median closing price of Monday's Dow Jones was 34.45 down 0.26 from Friday's Dow Jones median closing price of 34.71.
The highest closing price Monday was IBM $117.63 -0.01 0.01% 5,063,867 NYSE and the lowest closing price Monday again was Alcoa AA $11.3 +0.28 2.54% 31,246,855 NYSE.
The lowest volume Monday was again TRV Travelers $43.54 +0.32 0.74% 3,118,684 NYSE and the highest volume was $13.09 +0.58 4.64% 239,174,934 NYSE.
If Monday morning before the market opened you had purchased $100 of each of the Dow 30 shares (assuming you could buy fractional shares and assuming no transaction costs) and sold at the close you would have made $180 ($120,510 - $120,330).
Monday's Closing Dow closing numbers:
Symb/Last/Change/% Change/Vol./Market
T $25.73 +0.28 1.1% 26,226,400 NYSE
AA $11.3 +0.28 2.54% 31,246,855 NYSE
AXP $28.38 -1.13 3.83% 23,110,257 NYSE
BAC $13.09 +0.58 4.64% 239,174,934 NYSE
BA $42.24 -0.13 0.31% 5,668,332 NYSE
CAT $42.86 +0.86 2.05% 14,309,600 NYSE
CVX $68.85 +0.42 0.61% 7,775,113 NYSE
CSCO $21.84 -0.04 0.18% 31,567,003 NASDAQ-GS
KO $49.52 +0.16 0.32% 8,103,336 NYSE
DD $30.36 -0.32 1.07% 6,072,393 NYSE
DIS $26.45 +0.13 0.49% 9,766,899 NYSE
XOM $72.75 +0.46 0.64% 17,192,866 NYSE
GE $12.32 +0.29 2.41% 76,701,667 NYSE
HPQ $41.84 +0.12 0.29% 10,675,534 NYSE
HD $25.16 -0.16 0.63% 13,401,694 NYSE
INTC $19.47 +0.11 0.57% 42,289,301 NASDAQ-GS
IBM $117.63 -0.01 0.01% 5,063,867 NYSE
JPM $38.13 +0.21 0.55% 30,156,193 NYSE
JNJ $61.27 -0.24 0.39% 7,923,037 NYSE
KFT $28.26 +0.14 0.5% 7,621,564 NYSE
MCD $55.97 -0.11 0.2% 7,776,970 NYSE
MRK $30.77 -0.22 0.71% 20,045,051 NYSE
MSFT $23.11 -0.34 1.45% 80,838,132 NASDAQ-GS
PFE $16.62 +0.14 0.85% 47,367,688 NYSE
PG $55.78 -0.06 0.11% 6,815,073 NYSE
MMM $69.91 +0.49 0.71% 4,151,609 NYSE
TRV $43.54 +0.32 0.74% 3,118,684 NYSE
UTX $52.11 -0.12 0.23% 6,076,701 NYSE
VZ $31 0 -.50 1.59% 19,117,592 NYSE
WMT $48.97 +0.03 0.06% 14,257,043 NYSE
THE FOLLOWING WAS PUBLISHED IN MONDAY MORNING'S BLOG; POST #22:
A read of Monday's 7/27/09 print editions of: Wall Street Journal, AJC, Financial Times (no Dow Jones 30 mentions that I could find), USA Today, Barron's and 8/3/09 issues of Business Week and Time yielded the following stories about Dow Jones 30 component companies:
Barron's p15 says Tues GE Capital reveiws its financial condition and Thurs XOM ExxonMobil and Dis Disney will report quarterly results.
NYTimes lead story 7/27 Bus. Section pB1 says there is a proposed US Congress bill to curb drug commercials on tv and notes the PFE paid $147 million last year to advertising each of is Viagra and Lyrica drugs - Lyrica is for fibromyalgia and accouned for $1.4 billion in sales for '08 (Viagra did $0.9 billion).
Meanwhile, WSJ pB4 "EU Panel Rejects Merck KGaA's Erbitux for Lung Caner" saying a Eurpoean Union panel Friday issued a negative opinion on the use of Erbitux in non small cell lung cancer. Erbitux is approved for some types of bowel, head and neck cancers, and did sales of $802 bmiilion las year.
NYT pB5 says PG Procter & Gamble is using Bloggers to introduce its updated Swiffer Wet Jet cleaning mop.
WSJ pA3 lead story "Loans Shrink as Fear Lingers - Portfolios at Big Banks Fall 2.8% in Last Quarter; Instituions, Borrowers Both Wary" says lending continues to slow as bankers and borrowers refrain from taking risks. BAC BofA is listed as having in 2Q a loan portfolio of $942 bil down 3.6%; JPM JPMorgan's 2Q portfolio of $680.6 down 3.9% and AXP Amex is $62.9 billion down 3.2%. Related story at WSJ pC "Banks Profit From US Guarantee - Lenders' Earnings Reap the Benefit of FDIC Backing on Company Debt" notes GE will save about $24 billion in borrowing costs during the next 3 years because of the gov's guarantee which the story calls "the gift that keeps on giving" and says JPM's savings wil be $3.1 billion. It notes BofAm hasn't issued medium term guaranteed debt since March.
BofA may bring the bull logo back for its Merrill Lynch divisin per WSJ pC10 quoting one banker "Merrill without the bull is like Sueprman without a cape.
"JP Morgan Continues Push in Prime" is at WSJ pC3 and says JPM has reshuffled its senior equities staff in a bid to rpepare for a push into prime brokerage.
JPM's Jame Dimon is profiled on the front page p1B of USA Today's Money Section "Dimon's capital obsession pays off - JPMorgan Chase stakes claim as a front runner as CEO steers it through crisis" where it says that Dimon was praised by Pres. Obama for doing a pretty good job during the financail cris. JPM closed Friday at 37.92.
JPM got more good press at Time 8/3/09 p43 "Too Much Profit? - Goldman Sachs and JPMorgan Chase are raking it in because they're good - if not virtuous."
WSJ pB1 "Videogame Makers Can't Dodge Recession" says MSFT's Xbox 360 console sales has plummeted 38% int he last month.
WSJp pB1 in a story about TV networks giving discounts for ads bought in advance says HPQ Hewlett-Packard isn't biting; HPQ spent $69 million in TV ads in '08 but is waiting to decide to buy tv time. Related story at WSJ pB5 says GE's NBC, whose prime time lineup is in fourth place, has been signing deeals with rateds down 6% from last year and notes Dis Disney's ABC has lowered rates 3% from last year.
Sat WSJ had a great interview with CSCO's CEO John Chambers @ pA11 and says it will be competing with its former strategic partners, IBM and HPQ by intoducing a new integrated hardware/softwre platform - the Cisco Unified computing System.
8/3 issue of Business Week in "Tech Gets Ready for a Recovery" says INTC's stock has surged 31% this year on hopes of a rebound in consumer spending.
BRNs p8 'Yahoo - Microsoft Pact: Alive Again" is another story about speculation re: a potential advertising partnership between Yahoo and MSFT.
Bus Week p33 "Can The Military Find the Answer to Alternative Energy" says there is a big drive to create a viable alternative energy future and mentions IBM as being involved.
Bus Week p56 lits the top ten global brands with 7 of them being Dow Jones 30 stocks; here they are KO Coke, IBM, MSFT, GE, Nokia (not Dow co.); Toyota Motor (not a Dow 30) INTC Intel, MCD McDonald's, Dis Disney, and another non Dower, Google.
Bus Week p6 says CAT, Catepillar and PFE Pfizer's good earnings has shown some "tentative signs of stabilization" in the economy.
Bus Wk p13, Will Pfizer's Giveaway Drugs Polish Its Public Image" notes the 160 year old PFE has up to now never handed out free drugs in resposne to a recession but CEO Jeffrey Kinders now has a free drug program, called Maintain.
Bus Wk p11 says Robert Zagunis, of Jensen Investment Management owns JNJ Johnson & JOhnson but has sold MRK Merck and PFE Pfizer.
BWweek p21 says VZ's Verizon Wireless is joining with oher cariers to grab a piece of the mobile sofware market from phonemakers.
Barrons 7/27 at p33 in a story about elecronics retailer hhgregg's stock says WMT is ramping up its consumer elecronics businesses.
BRNs "Put It on Master Card" at p16 in a story about Mastercard says it charged off $2.5 billion for the settlement of long running antitrust suits by AXP Amex and Discover.
Barron's p25 "Microsoft Goes Macrosoft" says MSFT is no longer the dead ringer proxy for tech. The lack of enterprise demand for MSF products as reflected in its poor 2Q results reflects how bad the economy is despite statistical indications that the recession has bottomed.